Phase II evaluation of oral idarubicin (4-demethoxydaunorubicin) in patients with disseminated malignant melanoma

M. Lopez, L. Di Lauro, P. Papaldo, F. Ganzina, N. Di Pietro, B. Lazzaro

Research output: Contribution to journal › Article

6 Citations (Scopus)
Original languageEnglish
Pages (from-to)911-912
Number of pages2
JournalCancer Treatment Reports
Volume70
Issue number7
Publication statusPublished - 1986

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Lopez, M., Di Lauro, L., Papaldo, P., Ganzina, F., Di Pietro, N., & Lazzaro, B. (1986). Phase II evaluation of oral idarubicin (4-demethoxydaunorubicin) in patients with disseminated malignant melanoma. Cancer Treatment Reports, 70(7), 911-912.

Phase II evaluation of oral idarubicin (4-demethoxydaunorubicin) in patients with disseminated malignant melanoma. / Lopez, M.; Di Lauro, L.; Papaldo, P.; Ganzina, F.; Di Pietro, N.; Lazzaro, B.

In: Cancer Treatment Reports, Vol. 70, No. 7, 1986, p. 911-912.

Research output: Contribution to journal › Article

Lopez, M, Di Lauro, L, Papaldo, P, Ganzina, F, Di Pietro, N & Lazzaro, B 1986, 'Phase II evaluation of oral idarubicin (4-demethoxydaunorubicin) in patients with disseminated malignant melanoma', Cancer Treatment Reports, vol. 70, no. 7, pp. 911-912.
Lopez M, Di Lauro L, Papaldo P, Ganzina F, Di Pietro N, Lazzaro B. Phase II evaluation of oral idarubicin (4-demethoxydaunorubicin) in patients with disseminated malignant melanoma. Cancer Treatment Reports. 1986;70(7):911-912.
Lopez, M. ; Di Lauro, L. ; Papaldo, P. ; Ganzina, F. ; Di Pietro, N. ; Lazzaro, B. / Phase II evaluation of oral idarubicin (4-demethoxydaunorubicin) in patients with disseminated malignant melanoma. In: Cancer Treatment Reports. 1986 ; Vol. 70, No. 7. pp. 911-912.
@article{f76d3d2566854dcd9106e212ecc70547,
title = "Phase II evaluation of oral idarubicin (4-demethoxydaunorubicin) in patients with disseminated malignant melanoma",
author = "M. Lopez and {Di Lauro}, L. and P. Papaldo and F. Ganzina and {Di Pietro}, N. and B. Lazzaro",
year = "1986",
language = "English",
volume = "70",
pages = "911--912",
journal = "Cancer Treatment Reports",
issn = "0361-5960",
publisher = "U.S. National Cancer Institute",
number = "7",

}

TY - JOUR

T1 - Phase II evaluation of oral idarubicin (4-demethoxydaunorubicin) in patients with disseminated malignant melanoma

AU - Lopez, M.

AU - Di Lauro, L.

AU - Papaldo, P.

AU - Ganzina, F.

AU - Di Pietro, N.

AU - Lazzaro, B.

PY - 1986

Y1 - 1986

UR - http://www.scopus.com/inward/record.url?scp=0022469154&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022469154&partnerID=8YFLogxK

M3 - Article

C2 - 3459575

AN - SCOPUS:0022469154

VL - 70

SP - 911

EP - 912

JO - Cancer Treatment Reports

JF - Cancer Treatment Reports

SN - 0361-5960

IS - 7

ER -

Access to Document